Skip to main content
. 2018 Dec 1;11(12):5547–5560.

Figure 7.

Figure 7

Relationship between XPO1 alterations and survival in DLBCL (TCGA, provisional). A. Overall survival (OS): two out of 9 cases with alterations resulted in death, and the median survival time was 116.72 months. Seven out of 38 cases without alterations resulted in death, and the median survival time was 211.07 months; B. Disease-free survival (DFS): one of the 8 cases with alterations relapsed, and the median time of DFS was 120.53 months, whereas 11 of the 35 cases without alterations relapsed. Survival was analyzed using the Kaplan-Meier estimate provided by cBioPortal (www.cbioportal.org). Annotation: DLBCL, diffuse large B-cell lymphoma; XPO1, exportin-1; TCGA, The Cancer Genome Atlas.